HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enhancement of Lumbar Fusion and Alleviation of Adjacent Segment Disc Degeneration by Intermittent PTH(1-34) in Ovariectomized Rats.

Abstract
Osteoporosis, which is prevalent in postmenopausal or aged populations, is thought to be a contributing factor to adjacent segment disc degeneration (ASDD), and the incidence and extent of ASDD may be augmented by osteopenia. Parathyroid hormone (PTH) (1-34) has already been shown to be beneficial in osteoporosis, lumbar fusion and matrix homeostasis of intervertebral discs. However, whether PTH(1-34) has a reversing or retarding effect on ASDD in osteopenia has not been confirmed. In the present study, we evaluated the effects of intermittent PTH(1-34) on ASDD in an ovariectomized (OVX) rat model. One hundred 3-month-old female Sprague-Dawley rats underwent L4 -L5 posterolateral lumbar fusion (PLF) with spinous-process wire fixation 4 weeks after OVX surgery. Control groups were established accordingly. PTH(1-34) was intermittently administered immediately after PLF surgery and lasted for 8 weeks using the following groups (n = 20) (V = vehicle): Sham+V, OVX+V, Sham+PLF+V, OVX+PLF+V, OVX+PLF+PTH. The fused segments showed clear evidence of eliminated motion on the fusion-segment based on manual palpation. Greater new bone formation in histology was observed in PTH-treated animals compared to the control group. The extent of ASDD was significantly increased by ovariotomy. Intermittent PTH(1-34) significantly alleviated ASDD by preserving disc height, microvessel density, relative area of vascular buds, endplate thickness and the relative area of endplate calcification. Moreover, protein expression results showed that PTH(1-34) not only inhibited matrix degradation by decreasing MMP-13, ADAMTS-4 and Col-I, but also promote matrix synthesis by increasing Col-II and Aggrecan. In conclusion, PTH(1-34), which effectively improves lumbar fusion and alleviates ASDD in ovariectomized rats, may be a potential candidate to ameliorate the prognosis of lumbar fusion in osteopenia.
AuthorsZhuang Zhou, Fa-Ming Tian, Yu Gou, Peng Wang, Heng Zhang, Hui-Ping Song, Yong Shen, Ying-Ze Zhang, Liu Zhang
JournalJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research (J Bone Miner Res) Vol. 31 Issue 4 Pg. 828-38 (Apr 2016) ISSN: 1523-4681 [Electronic] United States
PMID26542457 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 American Society for Bone and Mineral Research.
Chemical References
  • Collagen Type I
  • Parathyroid Hormone
  • ADAMTS4 protein, rat
  • Matrix Metalloproteinase 13
  • Mmp13 protein, rat
  • ADAMTS4 Protein
Topics
  • ADAMTS4 Protein (metabolism)
  • Animals
  • Collagen Type I (metabolism)
  • Extracellular Matrix (metabolism, pathology)
  • Female
  • Intervertebral Disc Degeneration (chemically induced, metabolism, surgery)
  • Matrix Metalloproteinase 13 (metabolism)
  • Ovariectomy
  • Parathyroid Hormone (adverse effects, pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Spinal Fusion

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: